NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/07/2024
Back to search
Official data from USPTO
INCLINICO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
05/07/2024
Trademark type
Combined
Nice classes
9, 42
Filing date
08/05/2022
Registration date
05/07/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/07/2024
Last transaction
05/07/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
3
Owner type
99
Owner location
Central, HK
Examiner
SPILS, CAROL A
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized word "inClinico" in which the capital letter "C" is composed of a dashed curve with a scope icon inside. The letters "i" and "n" appearing before the capital "C" and the scope icon inside the "C" are in purple. The term "Clinico" is in black. The color white is not a part of the mark and represents transparent background area.
Holders and representatives
Holders
Insilico Medicine IP Limited
Representatives
Gregory J. Chinlund Marshall, Gerstein & Borun LLP
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Computerscomputer hardware and computer peripheral devices; downloadable computer application software for computersmobile phones and other portable media devices for clinical trial research and analysis; computer software platformsrecordedfor clinical trials and analysis; computer software platformsdownloadablefor clinical trial research and analysis; recorded computer software for clinical trial research and analysis and instructional user guides sold as a unit; downloadable computer programs for clinical trial research and analysis; computer programsrecordedfor clinical trial research and analysis; computer operating programsrecorded; data processing apparatus being data processors; data processing equipment; downloadable or recorded computer software using artificial intelligence and machine learning for clinical trial research and analysis; downloadable or recorded data sets using artificial intelligence for automated machine learning in the field of clinical trial research and analysis; electronic card readers; data processing equipmentscanners; downloadable machine learning software for clinical trial research and analysis
Class 42
Scientific and technological servicesresearch and design in the field of drug discoveryclinical trial research and analysis; software as a service (SAAS) featuring software using artificial intelligence for clinical trial research and analysis; platform as a service (PAAS) featuring computer software platforms for clinical trial researchoutcome forecast and analysis; creating and designing website based indexes of data and information in the field of drug discoveryclinical trial research and analysis for others using information technology; research and development of new scientific products for others in the field of drug discoveryMedical and scientific researchconducting clinical trial research and analysis for others; scientific and technological research relating to patent mapping; scientific research; research in the field of artificial intelligence
Publications
History of USPTO decisions and trademark events.
40 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/31/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/31/2024
OTHE
CASE RETURNED TO EXAMINATION
01/12/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
01/12/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
12/08/2023
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
12/08/2023
APET
ASSIGNED TO PETITION STAFF
12/07/2023
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
11/13/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
11/09/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/09/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/09/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/09/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/09/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/09/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/09/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/29/2023
PUBO
PUBLISHED FOR OPPOSITION
08/29/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/09/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/21/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/20/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/20/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/20/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/20/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/06/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
07/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/16/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
06/13/2023
ALIE
ASSIGNED TO LIE
06/13/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/08/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/08/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/08/2023
DOCK
ASSIGNED TO EXAMINER
05/20/2023
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/30/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/29/2022
NWAP
NEW APPLICATION ENTERED
08/09/2022
Continuous trademark protection
Get notified about every new filing that threatens INCLINICO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.